Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]

M A Dimopoulos¹, P Moreau², E Terpos¹, M V Mateos³, S Zweegman⁴, G Cook⁵, M Delforge⁶, R Hájek⁷, F Schjesvold⁸, M Cavo⁹, H Goldschmidt¹⁰, T Facon¹¹, H Einsele¹², M Boccadoro¹³, J San-Miguel¹⁴, P Sonneveld¹⁵, U Mey¹⁶; EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: guidelines@ehaweb.org

Affiliations

¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
³ University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.
⁴ Department of Hematology, Amsterdam, UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
⁵ Leeds Cancer Centre and University of Leeds, Leeds, UK.
⁶ Department of Hematology, University Hospital Leuven, Leuven, Belgium.
⁷ Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
⁸ Oslo Myeloma Center, Oslo, University Hospital, Oslo; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.
⁹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
¹⁰ University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
¹¹ Hôpital Claude Huriez, Lille University Hospital, Lille, France.
¹² Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany.
¹³ Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
¹⁴ Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
¹⁵ Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands.
¹⁶ Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.

PMID: 35810138
DOI: 10.1016/j.annonc.2022.05.004

Published Erratum

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]

M A Dimopoulos et al. Ann Oncol. 2022 Sep.

. 2022 Sep;33(9):988.

doi: 10.1016/j.annonc.2022.05.004. Epub 2022 Jul 6.

Authors

Affiliations

¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
³ University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.
⁴ Department of Hematology, Amsterdam, UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
⁵ Leeds Cancer Centre and University of Leeds, Leeds, UK.
⁶ Department of Hematology, University Hospital Leuven, Leuven, Belgium.
⁷ Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
⁸ Oslo Myeloma Center, Oslo, University Hospital, Oslo; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.
⁹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
¹⁰ University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
¹¹ Hôpital Claude Huriez, Lille University Hospital, Lille, France.
¹² Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany.
¹³ Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
¹⁴ Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
¹⁵ Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands.
¹⁶ Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.

PMID: 35810138
DOI: 10.1016/j.annonc.2022.05.004

No abstract available

PubMed Disclaimer

Erratum for

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].
Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U; EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: guidelines@ehaweb.org. Dimopoulos MA, et al. Ann Oncol. 2022 Jan;33(1):117. doi: 10.1016/j.annonc.2021.10.001. Epub 2021 Nov 29. Ann Oncol. 2022. PMID: 34857439 No abstract available.

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]

Affiliations

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]

Authors

Affiliations

Erratum for

Publication types